Oligonucleotide Therapeutics & Delivery conference Sep 22-23, LONDON, UK

Amotz Shemi, CEO, Silenseed will address ” Recent clinical progress with RNAi loaded KRAS-LODER for pancreatic tumor” on Thursday 23rd September 2021 • Introducing the RNAi loaded KRAS-LODER for targeting KRAS mutations• Overviewing recent clinical success in phase II trials• Presenting phase II clinical trials results including primary and secondary endpoints• Outlining next steps of […]